{"id":13873,"date":"2015-01-23T11:48:47","date_gmt":"2015-01-23T02:48:47","guid":{"rendered":"http:\/\/mus0.mus.rbrc.jp\/en\/?page_id=13873"},"modified":"2015-01-23T11:48:47","modified_gmt":"2015-01-23T02:48:47","slug":"lcmv-rt-pcr2006","status":"publish","type":"page","link":"http:\/\/mus.brc.riken.jp\/en\/protocol\/microbiological\/lcmv-rt-pcr2006","title":{"rendered":"Establishment of RT-PCR Test for Detection of      Lymphocytic Choriomeningitis Virus"},"content":{"rendered":"<h5>1.Overview:<\/h5>\n<p style=\"padding-left: 30px;\">The lymphocytic choriomeningitis virus (LCMV) causes either acute or persistent infection in rodents, and opportunistic infection in humans. In order to detect LCMV infection in our mouse colony, we have established a protocol for RT-PCR test which can amplify the nucleoprotein (NP) region of LCMV small (S) RNA using RNA extracted from mouse kidneys.<\/p>\n<h5>2.Background:<\/h5>\n<p style=\"padding-left: 30px;\">RIKEN BRC and the National Institute of Infectious Diseases isolated the LCMV which infected the MAI\/Pas mouse colony, then determined whole sequences of S RNA. Using this sequence information and the reported LCMV S RNA sequences found on the public databases, we designed the degenerate primer set written below which can amplify the NP region of the isolated LCMV, LCMV Armstrong and LCMV WE strains and set the reaction condition.<\/p>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\">Primer:<\/td>\n<td style=\"background-color: white; text-align: left; width: 80px; border: 0px;\"><b>NP5-001<\/b><\/td>\n<td style=\"background-color: white; text-align: left; border: 0px;\"><b>5&#8242;-tccatragwgcacagtgyggggtgat-3&#8242;<\/b><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; border: 0px;\"><\/td>\n<td style=\"background-color: white; border: 0px;\"><b>NP3-001<\/b><\/td>\n<td style=\"background-color: white; border: 0px;\"><b>5&#8242;-gcatgggaraayacracaattgayc-3&#8242;<\/b><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; border: 0px;\"><\/td>\n<td style=\"background-color: white; border: 0px;\" colspan=\"2\"><b>r =a or g, w = a or t, y =c or t<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h5>3.Materials and methods:<\/h5>\n<p>1) RNA extraction<\/p>\n<p style=\"padding-left: 30px;\">RNA was extracted from 5 mg of kidney tissues using a QuickGene RNA tissue kit S (Fujifilm Co., Ltd., Tokyo, Japan) by a beads cell disrupter (ZB-50 and MicroSmash MS-100R, Tomy Seiko Co., Ltd., Tokyo, Japan) and automated extraction system (QuickGene-800, Fujifilm Co., Ltd,. Tokyo, Japan). Concentration of the finally obtained RNA was 500 to 1,000 ng\/\u03bcl.<\/p>\n<p>2) cDNA synthesis<\/p>\n<p style=\"padding-left: 30px;\">cDNA was synthesized using SuperScript II (18064-071, Invitrogen Corp., Carlsbad, CA, USA) and random primer (C1181, Promega Corp., Madison, WI, USA).<\/p>\n<p style=\"padding-left: 30px;\">Reaction mixture:<\/p>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 180px; border: 0px;\">ddH2O<\/td>\n<td style=\"background-color: white; text-align: right; width: 50px; border: 0px;\">1.25 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 180px; border: 0px;\">5 x Buffer<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">2.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 180px; border: 0px;\">dNTP (2.5 mM)<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">1.25 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 180px; border: 0px;\">DTT (0.1 M)<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">1.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 180px; border: 0px;\">Random primer (500 \u03bcg\/ml)<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">0.5 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 180px; border: 0px;\">Extracted RNA<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">3.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"padding-left: 30px;\">Reaction mixture above was prepared and incubated at 70\u00b0C for 3 minutes, at 55\u00b0C for 90 seconds and at 37\u00b0C for 1 minute. One \u03bcl of SuperScript II was then added to the mixture to make the final volume of 10 \u03bcl. cDNA was synthesized by the incubation of the mixture at 37\u00b0C for 20 minutes and at 98\u00b0C for 5 minutes.<\/p>\n<p>3) Preparation of PCR reaction mixture<\/p>\n<p style=\"padding-left: 30px;\">QIAGEN Multiplex PCR kit (131965, QIAGEN Inc., Hilden, Germany) was used. The PCR reaction mixture was as follows:<\/p>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 200px; border: 0px;\">ddH2O<\/td>\n<td style=\"background-color: white; text-align: right; width: 50px; border: 0px;\">6.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 200px; border: 0px;\">primer: NP5-001 (10 \u03bcM)<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">1.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 200px; border: 0px;\">primer: NP3-001 (10 \u03bcM)<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">1.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 200px; border: 0px;\">synthesized cDNA<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">2.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: left; width: 200px; border: 0px;\">2 x QIANGE Multiplex Master Mix<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">10.0 \u03bcl<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>4) PCR reaction<\/p>\n<p style=\"padding-left: 30px;\">The detection of LCMV was performed using a degenerate primer set of NP5-001 and NP3-001 described above which amplified the NP region of LCMV S RNA. Control PCR was executed to ascertain the RNA extraction and cDNA synthesis using a primer pair that amplified glyceraldehyde-3-phosphate dehydrogenase (G3PDH, PCR-301, Toyobo Co., Ltd., Osaka, Japan).<\/p>\n<p style=\"padding-left: 30px;\">PCR condition:<\/p>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">95\u00b0C<\/td>\n<td style=\"background-color: white; text-align: right; width: 100px; border: 0px;\">15 minutes<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\"><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">94\u00b0C<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">30 minutes<\/td>\n<td style=\"background-color: white; text-align: center; border: 0px;\" rowspan=\"3\" align=\"center\" valign=\"middle\"><img loading=\"lazy\" decoding=\"async\" alt=\"\" src=\"\/en\/wp-content\/uploads\/2013\/05\/lcmv_rt_pcr2006_01.png\" width=\"13\" height=\"75\" \/><\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">60\u00b0C<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">90 minutes<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">x 30 cycles<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">72\u00b0C<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">90 minutes<\/td>\n<\/tr>\n<tr>\n<td style=\"background-color: white; text-align: right; width: 180px; border: 0px;\"><\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">72\u00b0C<\/td>\n<td style=\"background-color: white; text-align: right; border: 0px;\">10 minutes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>5) Electrophoresis<\/p>\n<p style=\"padding-left: 30px;\">Ten \u03bcl of PCR products were applied to agarose gel electophoresis. Electrophoresis was performed on 2% agarose gel in 1 x TAE buffer for 100V, 30 minutes, using one hundred base pair ladder marker (15628-050, Invitrogen Corp., Carlsbad, CA, USA).<\/p>\n<h5>4.Results:<\/h5>\n<p style=\"padding-left: 30px;\">The typical results are shown below (Figure 1). RT-PCR clearly demonstrated that only MAI\/Pas mice carried LCMV.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3949\" alt=\"lcmv_rt_pcr2006_02\" src=\"\/en\/wp-content\/uploads\/2013\/05\/lcmv_rt_pcr2006_02.png\" width=\"700\" height=\"397\" srcset=\"http:\/\/mus.brc.riken.jp\/en\/wp-content\/uploads\/2013\/05\/lcmv_rt_pcr2006_02.png 700w, http:\/\/mus.brc.riken.jp\/en\/wp-content\/uploads\/2013\/05\/lcmv_rt_pcr2006_02-300x170.png 300w, http:\/\/mus.brc.riken.jp\/en\/wp-content\/uploads\/2013\/05\/lcmv_rt_pcr2006_02-150x85.png 150w, http:\/\/mus.brc.riken.jp\/en\/wp-content\/uploads\/2013\/05\/lcmv_rt_pcr2006_02-400x226.png 400w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/p>\n<p>Figure 1. M:\u00a0one hundred base pair ladder marker (15628-050, Invitrogen Corp., Carlsbad, CA, USA)<\/p>\n<p style=\"padding-left: 30px;\">Lane 1:Strain A (LCMV negative),\u00a0\u00a0Lane 2:\u00a0Strain B (LCMV negative)<br \/>\nLane 3:Strain C (LCMV negative),\u00a0\u00a0Lane 4:\u00a0MAI\/Pas (LCMV positive)<\/p>\n<h5>5.Conclusion:<\/h5>\n<p style=\"padding-left: 30px;\">We could establish a reliable RT-PCR test to detect LCMV NP region in a persistently-infected mouse.<\/p>\n<p style=\"padding-left: 30px;\">Acknowledgement:<br \/>\nWe acknowledge Dr. Shigeru Morikawa at the National Institute of Infectious Diseases, Tokyo, Japan for his overall cooperation in the virus isolation, S RNA sequence and RT-PCR.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Fumio Ike, Ph.D.,<br \/>\nHatsumi Nakata, Ph.D.,<br \/>\nAtsushi Yoshiki, Ph.D.<\/p>\n<p>Experimental Animal Division<br \/>\nRIKEN BioResource Center<\/p>\n","protected":false},"excerpt":{"rendered":"<p>1.Overview: The lymphocytic choriomeningitis virus (LCMV) causes either acute or persistent infection in rodents, and opportunistic infection in humans. In order to detect LCMV infection in our mouse colony, we have established a protocol for RT-PCR test which can amplify the nucleoprotein (NP) region of LCMV small (S) RNA using RNA extracted from mouse kidneys. 2.Background: RIKEN BRC and the National Institute of Infectious Diseases isolated the LCMV which infected the MAI\/Pas mouse colony, then determined whole sequences of S RNA. Using this sequence information and the reported LCMV S RNA sequences found on the public databases, we designed the degenerate primer set written below which can amplify the NP region of the isolated LCMV, LCMV Armstrong and LCMV WE strains and set the reaction condition. Primer: NP5-001 5&#8242;-tccatragwgcacagtgyggggtgat-3&#8242; NP3-001 5&#8242;-gcatgggaraayacracaattgayc-3&#8242; r =a or g, w = a or t, y =c or t 3.Materials and methods: 1) RNA extraction RNA was extracted from 5 mg of kidney tissues using a QuickGene RNA tissue kit S (Fujifilm Co., Ltd., Tokyo, Japan) by a beads cell disrupter (ZB-50 and MicroSmash MS-100R, Tomy Seiko Co., Ltd., Tokyo, Japan) and automated extraction system (QuickGene-800, Fujifilm Co., Ltd,. Tokyo, Japan). Concentration of the finally [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":13867,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-13873","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/13873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=13873"}],"version-history":[{"count":1,"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/13873\/revisions"}],"predecessor-version":[{"id":13874,"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/13873\/revisions\/13874"}],"up":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/13867"}],"wp:attachment":[{"href":"http:\/\/mus.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=13873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}